Oxford Drug Design raises £2.2M to develop AI-based drug discovery programme
Biotechnology agency Oxford Drug Design Limited (ODD) has raised £2.2M in funding from present buyers ACF Buyers, o2h Ventures, Meltwind Advisory, a number of returning angels and new buyers and the US-based R42 Group.
The Oxford College spinout has created a synthetic intelligence (AI) AI proprietary platform for drug discovery, centered on unmet therapeutic wants in oncology.
Alan D Roth, CEO, ODD, mentioned: “This newest funding will allow us to construct on and speed up our profitable computational design-led discovery focus. We’re excited to be enjoying a pivotal function within the innovation of oncological remedies main to raised outcomes for most cancers sufferers worldwide.”
Rune Labs launch Portuguese subsidiary to enhance diabetes care
Precision neurology software program and information platform firm Rune Labs has introduced the creation of a staff of lead designers primarily based in Lisbon, Portugal.
The brand new staff shall be centered on increasing options and workflows for Rune Labs’ StrivePD ecosystem for Parkinson’s care. The subsidiary may even be Rune’s first everlasting presence in Europe.
Will Newby, VP of product, Rune Labs, mentioned: “Rune Labs is targeted on enabling human-centred care to individuals dwelling with Parkinson’s, and the Portugal staff of product designers will make sure that sufferers, clinicians, and researchers have a voice in our merchandise.”
Babylon GP at Hand opens two new clinics in London
Babylon GP at Hand has opened two new clinics in London that may present sufferers with face-to-face appointments alongside its digital-first built-in care.
The primary clinic in Dean Farrar Road, Victoria, opened final week and shall be adopted by a clinic in Drummond Road, Euston, subsequent month.
Dr Matthew Noble, UK medical director, Babylon, mentioned: “In-person care is so vital alongside highly-accessible digital appointments and we’re actually excited to launch these two new clinics for our Babylon GP at Hand sufferers in London.”
CDP Enterprise Capital launches digital well being startup accelerator
CDP Venture Capital Sgr has introduced the launch of an accelerator for digital well being startups, with a give attention to revolutionary options for respiratory ailments, ophthalmology, ladies’s well being, uncommon ailments and continual ache administration.
The VITA programme has been arrange along with Healthware Group and Danish accelerator Accelerace with complete belongings beneath administration of Є6.35 million.
Roberto Ascione, CEO and founder, Healthware Group, mentioned: “The VITA accelerator is testomony to Healthware’s dedication to contributing to the digital well being transformation, supporting the expansion and growth of probably the most promising startups.”
Applications are open to Italian startups and worldwide startups meaning to arrange registered places of work in Italy, till 12 June.
Medical trial finds blood check can determine 79% of early-stage bowel most cancers
A major care scientific trial in West Wales discovered {that a} blood check was in a position to choose up 79% of early-stage bowel cancers and 100% of superior bowel cancers.
The Raman Spectrometry (RS) blood check was developed by Swansea College spin-out CanSense, with funding from Most cancers Analysis Wales and Well being and Care Analysis Wales.
CanSense have additionally secured £1.2 million from the Nationwide Institute for Well being and Care Analysis (NIHR) to additional develop the blood check to make use of in scientific follow throughout Wales.
Dr Cerys Jenkins, cofounder and director, CanSense, mentioned: “Having this check obtainable on the triage stage would save time, cash, however most significantly save the sufferers from nervousness and pointless diagnostic checks.”
AI most cancers diagnostics firm wins life science innovation award
British AI startup Behold.AI has received Finest UK Digital Well being Answer on the Prix Galien awards.
The agency was awarded for its purple dot® scientific evaluation software program for detecting lung most cancers from X-rays, which is in use at a number of NHS hospital websites as a part of an impartial validation on affected person information.
Simon Rasalingham, CEO and chairman, Behold.AI, mentioned: “The peer-reviewed proof we’ve constructed up exhibits that if we roll this expertise out nationally we are able to add within the equal of 233 NHS guide radiologists, which is equal to 255,000 hours of guide time per 12 months.”
